About OvuSense
OvuSense is a Consumer company based in Warwick (United Kingdom) founded in 2006. OvuSense is recognized for providing ovulation tracking solutions. It operates on a Direct-to-Consumer (D2C) and HealthTech model in Consumer, Healthcare, and Technology sectors. OvuSense has raised $776.13 thousand across 2 funding rounds. The company has 8 employees. Its chief executive, as recorded, is Robert Crowther Milnes. Its website ovusense.com draws about 20 thousand monthly visits. OvuSense offers products and services including OvuCore Sensor and OvuFirst Sensor. Its focus areas include Medical Devices and Fertility Technology. Its legal entity is viO HealthTech Inc. Its competitors include MyHealthChecked, Monica Healthcare and Sensiia; 2 of its 3 listed competitors have raised funding.
Company details
OvuSense is focused on fertility and ovulation tracking through innovative medical devices. Solutions are offered for women with irregular periods or PCOS, utilizing patented core body temperature technology. The sector primarily served is healthcare, with an emphasis on reproductive health. Products like OvuCore and OvuFirst sensors are designed to predict and confirm ovulation with high accuracy, aiding conception planning and cycle regulation.
- Headquarters Warwick, United Kingdom
- Employees 8
- SectorsConsumerHealthcare Technology
- Email••••••••
- Phone•••• ••••
- Website ovusense.com
- Social LinkedIn X Facebook Instagram
- Legal Name Vio Healthtech Inc
- Total Equity Funding$776.13K (USD)
in 2 rounds
- Latest Funding Round$215.01K (USD), Seed
Dec 2023
- Employee Count8
Products & Services of OvuSense
OvuSense offers a comprehensive portfolio of products and services, including OvuCore Sensor and OvuFirst Sensor.
Ovulation is confirmed with 99% accuracy using vaginal sensor.
Skin sensor confirms ovulation window with over 90% accuracy.
Funding Insights of OvuSense
OvuSense has successfully raised a total of $776.13K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $215.01 thousand completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $776,134
- Total Rounds 2
- Last Round Seed — $215,012
- First Round $561,122
(Jul 2015)
All 2 funding rounds of OvuSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $215,012 | Seed | – | – | – |
| Jul 2015 | $561,122 | Seed | – | – | – |
People of OvuSense
1 people are tracked at OvuSense (1 in leadership); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Robert Crowther Milnes | CEO | Leadership |
Complete people profiles for OvuSense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OvuSense
3 dated milestones of OvuSense across 17 years, from founding to its latest funding, stage changes and deals.
- Founded OvuSense is founded.
- Funding First funding round of $561K.
- Funding Latest funding round, Seed, of $215K.
Competitors of OvuSense
OvuSense has 3 listed competitors in our database, 2 of them funded. They include MyHealthChecked, Monica Healthcare and Sensiia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| myhealthchecked.com | 2008 | Cardiff, United Kingdom | 21 | Online platform for ordering Covid-19 diagnostic test kits is operated. | ||
| monicahealthcare.com | 2005 | Nottingham, United Kingdom | $7.57M | 8 | Wearable devices for fetal and maternal health management are developed. | |
| sensiia.com | 2007 | Cambridge, United Kingdom | $6.4M | 4 | Provides a handheld device for fertility monitoring. |
Detailed competitors of OvuSense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of OvuSense
The website of OvuSense (ovusense.com) receives about 19.7K visits a month.
- Monthly visits19.7K
▲ 34.1% vs previous month
Websites whose visitors overlap most with OvuSense. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fertilityfriend.com | 100% | #400,852 | View details | ||
| premom.com | 98% | #271,082 | View details | ||
| proovtest.com | 97% | 131.2K | #321,407 | View details | |
1stchoice.org | 1stchoice.org | 94% | #4,237,322 | – | |
| pfcla.com | 83% | 75.3K | #517,783 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 23 similar websites and full traffic analytics for OvuSense
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ovusense
Complete news archive for OvuSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OvuSense
OvuSense was founded in 2006 and raised its 1st funding round 9 years after it was founded.
OvuSense is headquartered in Warwick, United Kingdom.
Robert Crowther Milnes is the CEO of OvuSense, as recorded in our data.
OvuSense is a funded company, having raised a total of $776.13K across 2 funding rounds to date. The company's 1st funding round was a Seed of $561.12K, raised on Jul 2015.
OvuSense has 8 employees.
OvuSense is focused on fertility and ovulation tracking through innovative medical devices. Solutions are offered for women with irregular periods or PCOS, utilizing patented core body temperature technology. The sector primarily served is healthcare, with an emphasis on reproductive health. Products like OvuCore and OvuFirst sensors are designed to predict and confirm ovulation with high accuracy, aiding conception planning and cycle regulation.
OvuSense's top competitors include MyHealthChecked, Monica Healthcare and Sensiia.
OvuSense offers OvuCore Sensor and OvuFirst Sensor.
OvuSense operates through Vio Healthtech Inc.